Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Mitoxantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 21 Leukemia 13 Lymphoma 8 Leukemia, Erythroblastic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Monocytic, Acute 7 Leukemia, Megakaryoblastic, Acute 7 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Large-Cell, Immunoblastic 4 Leukemia, Promyelocytic, Acute 3 Congenital Abnormalities 3 Breast Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Neutropenia 2 Myeloproliferative Disorders 2 Sarcoma, Myeloid 1 Recurrence 1 Pain 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Fentanyl 7 Zoledronic Acid 6 Radiotherapy 6 Ibandronic Acid 6 Morphine 5 Ketamine 5 Hydromorphone 5 nabiximols 4 Tapentadol 4 Oxycodone 4 Analgesia 4 alvimopan 3 Lidocaine 3 Acupuncture Therapy 3 Acetaminophen 3 Tetrodotoxin 2 Ropivacaine 2 Gabapentin 2 Docetaxel 2 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1 cabozantinib 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Taxes 1 Sugars 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01522443 2018-05-23

COMET-2

Exelixis

Phase 3 Terminated

119 enrolled 21 charts

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡